Cite

APA Citation

    Goel, S., & Tolaney, S. M. (2019). cDK4/6 inhibitors in breast cancer: a role in triple-negative disease?. Lancet oncology, 20(11), 1479–1481. http://access.bl.uk/ark:/81055/vdc_100094620855.0x000013
  
Back to record